Searchable abstracts of presentations at key conferences on calcified tissues

ba0002p94 | (1) | ICCBH2013

Bone anomalies in Noonan syndrome

Bodescu Ioana , Rusu Cristina , Idriceanu Jeanina , Vasiliu Ioana , Vulpoi Carmen , Constantinescu Georgiana

Background: Noonan syndrome (NS) is a genetic multisystem disorder characterized by distinctive facial features, learning difficulties, short stature, and cardiac defects. Other important findings include skeletal anomalies, especially spinal and chest deformities. Skeletal dysplasia was proven to be secondary to a disorder of RAS-mitogen activated protein kinase (MAPK) pathway which is essential for regulation of cell differentiation and growth including bone homeostasis. We ...

ba0002p138 | (1) | ICCBH2013

Rare mutations associated with osteoclast-poor osteopetrosis provide molecular insights into receptor activator of NFκβ signalling

Crockett Julie , Das Subhajit , Dignan Cahal , Mellis David , Duthie Angela , Sobacchi Cristina , Schulz Ansgar , Helfrich Miep

Twelve different mutations in TNFRSF11A (encoding the RANK receptor) have been associated with osteoclast-poor autosomal recessive osteopetrosis in patients. Two truncated RANK proteins resulting from substitution mutations (W434X and G280X), identified in two infants, cause loss of the intracellular oligomerisation motif and in the case of the G280X mutation the TRAF6 binding domain. A third mutation was identified in a 10-year-old patient and is a frameshift mutatio...

ba0003pp83 | Bone development/growth and fracture repair | ECTS2014

Serum serotonin: useful for the assessment of the bone metabolism status?

Poiana Catalina , Carsote Mara , Radoi Valentin , Mihai Alexandra , Geleriu Andreea , Capatana Cristina , Trifanescu Raluca , Opris Daniela

Introduction: Atypical markers will provide interesting information in order to assess the bone metabolism. Serotonin has a dual action related to the bone and its serum level is the easiest to use in daily clinical practice also the exact value is not very well described up to this moment.Aim: We correlate to serum levels of serotonin with different results of clinical bone health evaluation in menopausal women.Materials and metho...

ba0003pp98 | Cancer and bone: basic, translational and clinical | ECTS2014

Biological markers of aggressive giant cell tumour of bone: an immunohistochemical study

Quattrini Irene , Pazzaglia Laura , Conti Amalia , Novello Chiara , Ferrari Cristina , Benassi Maria Serena

Giant cell tumour of bone (GCTb) is an osteolytic neoplasia with tendency to local recurrence (10–25%), while metastases or malignant transformation are described in 1–4% of cases.It is composed by three distinct populations that cross-talk each other generating unbalance in bone remodeling and activation of NF-kB signaling pathway.To identify new candidate biological markers useful for improving clinical management of GC...

ba0003pp305 | Osteoporosis: treatment | ECTS2014

Treatment with PTH 1--84 influences glucose metabolism trough undercarboxylated osteocalcin

D'Amelio Patrizia , Spertino Elena , Sassi Francesca , Buondonno Ilaria , Tamone Cristina , Piano Simonetta , Isaia Giovanni Carlo

In the recent years the role of the skeleton in glucose and energy homeostasis has been studied. In particular the osteoblast-specific protein osteocalcin (OC), in its undercarboxylated form (uOC) has been shown to influence glucose homeostasis in animal models.The aim of our study is to evaluate if the intermittent administration of 1–84 PTH could influence glucose metabolism through its anabolic action on the skeleton.We enr...

ba0004op7 | (1) | ICCBH2015

Lessons from homocystinuria: Cystathionine beta-synthase as a novel marker for osteogenic differentiation of human mesenchymal stem cells

Gambari Laura , Manferdini Cristina , Gabusi Elena , Paolella Francesca , Lisignoli Gina , Mariani Erminia , Grassi Francesco

Objective: Classical homocystinuria due to cystathionine beta-synthase (CBS) deficiency, is a rare autosomal recessively inherited disease characterized by the multiple involvement on different organs. While the most striking cause of morbidity and mortality is thromboembolism, patients develop a marked osteoporosis at early age along with many other skeletal abnormalities. As CBS normally converts homocysteine to cystathionine, the result of CBS deficiency is an accumulation ...

ba0005p162 | Cell biology: osteoblasts and bone formation | ECTS2016

RCOR2 is a novel regulator of osteoblast differentiation

Tarkkonen Kati , Al Majidi Rana , Valensisi Cristina , Saastamoinen Lauri , Hawkins David , Kiviranta Riku

Epigenetic mechanisms regulating osteoblast differentiation are still inadequately described. In a genome wide transcriptional profiling of MC3T3-E1 osteoblastic cell line, we identified RCOR2 as a significantly upregulated gene during a differentiation time-course from proliferative to mature osteoblasts. Similar expression profile of RCOR2 was found in mouse calvarial osteoblasts. RCOR2 belongs to CoREST/RCOR family of proteins that regulate action of lysine-specific histone...

ba0006p132 | (1) | ICCBH2017

Anti-RANKL treatment in a murine model of fibrous dysplasia

Palmisano Biagio , Labella Rossella , Spica Emanuela , Remoli Cristina , Corsi Alessandro , Robey Pamela , Riminucci Mara

Fibrous dysplasia of bone (FD) is a crippling skeletal disease caused by activating mutations (R201C, R201H) of the Gsα gene. We recently generated GsαR201C transgenic mice that develop a FD skeletal phenotype. The analyses of these mice demonstrated that increased bone resorption is one of the main morbidity factors in FD and that RANKL is the major molecular mediator of osteolysis at affected skeletal sites.Ob...

ba0007p173 | (1) | ICCBH2019

Motor and nutritional aspects of individuals with osteogenesis imperfecta assisted in Brazilian midwest region

Castro Luiz Claudio de , Coelho Giovana , Luiz Livia , David Ana Cristina de

Objective: To characterize a group of children with Osteogenesis Imperfecta (OI) followed up at the University Hospital of Brasília (HUB), Brazil.Methods: Data were collected with children and adolescents that were hospitalized in the HUB for intravenous pamidronate infusion treatment. This hospital is an OI reference center of the Midwest region in Brazil. The sample consisted of thirty-eight subjects, of which 50% were female. 52% of the children ...